SCHEMBL25759570

SCHEMBL25759570

CC(C)c1ccc(N)cc1S(=O)(=O)Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.39
SLC9A1 P19634 2/20 0.38
SLC9A2 Q9UBY0 1/20 0.38
ANPEP P15144 1/20 0.36
TRPV4 Q9HBA0 2/20 0.36
ALDH1A1 P00352 5/20 0.35
CYP3A4 P08684 2/20 0.35
TSHR P16473 2/20 0.35
RECQL P46063 2/20 0.35
HPGD P15428 2/20 0.35
THRB P10828 1/20 0.35
ALOX15 P16050 1/20 0.35
CASP1 P29466 1/20 0.35
HSD17B10 Q99714 1/20 0.35
HSD11B1 P28845 1/20 0.34
TDP1 Q9NUW8 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
GAA P10253 2/20 0.33
RAPGEF4 Q8WZA2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15651278 0.83 KDM4E (0.41) L3MBTL1SLC9A1SLC9A2ANPEPALDH1A1
SCHEMBL157770 0.81 RAPGEF4 (0.47) L3MBTL1SLC9A1SLC9A2ANPEPALDH1A1
SCHEMBL1929488 0.79 TRPV4 (0.44) SLC9A1SLC9A2TRPV4ALDH1A1TSHR
SCHEMBL25754886 0.79 LMNA (0.47) SLC9A1SLC9A2TRPV4ALDH1A1HPGD
SCHEMBL25759568 0.75 SLC9A1 (0.39) SLC9A1SLC9A2TRPV4ALDH1A1HPGD
SCHEMBL8493031 0.75 L3MBTL1 (0.52) L3MBTL1TRPV4ALDH1A1CYP3A4TSHR
SCHEMBL7027875 0.74 TRPV4 (0.37) L3MBTL1SLC9A1TRPV4ALDH1A1MEN1
SCHEMBL30534761 0.74 TRPV4 (0.37) L3MBTL1SLC9A1TRPV4ALDH1A1MEN1
SCHEMBL31587739 0.74 ACE2 (0.50) SLC9A1SLC9A2TSHRHSD17B10TDP1
SCHEMBL3971731 0.74 ACE2 (0.50) SLC9A1SLC9A2TSHRHSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF TRAP1, PINK1, TP53BP1 L3MBTL1 2375/4885SLC9A1 1050/4885SLC9A2 2907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.